---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-047063"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2026-10-14T21:28:05+00:00"
generated_at: "2026-10-14T21:30:06.668145+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ENvue Medical raises up to $1M secured from Alpha Capital; Series X conversion cut to $0.50

## Summary
- Entered Secured Promissory Note with Alpha Capital Anstalt for up to $1,000,000; $250,000 initial tranche funded Oct 8, 2026.
- Note accrues 10% interest, rising to 18% on default; matures Dec 31, 2026 and lender may extend in 3-month increments to Dec 31, 2028.
- Secured by substantially all assets: accounts, inventory, manufacturer deposits, patents, trademarks, copyrights and subsidiary equity.
- Series X Preferred conversion price lowered to $0.50/share; holders of at least 70% amended the dilutive-issuance price adjustment terms.
- Certificate of Amendment filed with Delaware Secretary of State Oct 12, 2026; CEO Doron Besser signed the report.

## SEC filing metadata
- accession: 0001493152-26-047063
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2026-10-14T21:28:05+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315226047063/0001493152-26-047063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315226047063/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-047063
- JSON: https://secwatch.observer/filing/0001493152-26-047063.json
- Plain text: https://secwatch.observer/filing/0001493152-26-047063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.